Catalyst Wire Dossier Catalyst Wire Dossier

Glycated albumin intervention

· Asahi Kasei Therapeutics Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glycated albumin intervention, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes [NA]

See pricing